Structural basis for oligosaccharide recognition of misfolded glycoproteins by OS-9 in ER-associated degradation

Mol Cell. 2010 Dec 22;40(6):905-16. doi: 10.1016/j.molcel.2010.11.017.

Abstract

Misfolded glycoproteins are translocated from endoplasmic reticulum (ER) into the cytosol for proteasome-mediated degradation. A mannose-6-phosphate receptor homology (MRH) domain is commonly identified in a variety of proteins and, in the case of OS-9 and XTP3-B, is involved in glycoprotein ER-associated degradation (ERAD). Trimming of outermost α1,2-linked mannose on C-arm of high-mannose-type glycan and binding of processed α1,6-linked mannosyl residues by the MRH domain are critical steps in guiding misfolded glycoproteins to enter ERAD. Here we report the crystal structure of a human OS-9 MRH domain (OS-9(MRH)) complexed with α3,α6-mannopentaose. The OS-9(MRH) has a flattened β-barrel structure with a characteristic P-type lectin fold and possesses distinctive double tryptophan residues in the oligosaccharide-binding site. Our crystallographic result in conjunction with nuclear magnetic resonance (NMR) spectroscopic and biochemical results provides structural insights into the mechanism whereby OS-9 specifically recognizes Manα1,6Manα1,6Man residues on the processed C-arm through the continuous double tryptophan (WW) motif.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Carbohydrate Conformation
  • Crystallography, X-Ray
  • Endoplasmic Reticulum / metabolism*
  • Glycoproteins / chemistry*
  • Glycoproteins / metabolism*
  • Humans
  • Lectins / chemistry
  • Lectins / metabolism*
  • Models, Molecular
  • Neoplasm Proteins / metabolism*
  • Nuclear Magnetic Resonance, Biomolecular
  • Oligosaccharides / chemistry*
  • Oligosaccharides / metabolism*
  • Protein Folding*
  • Receptor, IGF Type 2 / chemistry
  • Receptor, IGF Type 2 / metabolism

Substances

  • ERLEC1 protein, human
  • Glycoproteins
  • Lectins
  • Neoplasm Proteins
  • OS9 protein, human
  • Oligosaccharides
  • Receptor, IGF Type 2